Transaction Date | Recipient | Shares | Type | Price | Value |
---|---|---|---|---|---|
15th December 2020 | Mark A Sirgo | 230,769 | Open or private purchase | $0.65 | $149,999.85 |
15th December 2020 | John Temperato | 153,846 | Open or private purchase | $0.65 | $99,999.90 |
15th December 2020 | Edward J Sitar | 61,538 | Open or private purchase | $0.65 | $39,999.70 |
2nd December 2020 | Israel Gp Ltd. Orbi Med | 103,200 | Open or private sale | $21.60 | $2,229,120.00 |
27th November 2020 | John Temperato | 203,667 | Grant/award etc. | $0.00 | |
9th November 2020 | Lorin K Johnson | 4,262 | Exercise of in-the-money or at-the-money derivatives securities (usually options) | $4.00 | $17,048.00 |
30th October 2020 | Israel Gp Ltd. Orbi Med | 1,943,734 | Other acquisition or disposition | $0.00 | |
30th October 2020 | Nissim Darvish | 1,943,734 | Other acquisition or disposition | $0.00 | |
30th October 2020 | Mark A Sirgo | 4,513 | Other acquisition or disposition | $0.00 | |
30th October 2020 | John Temperato | 4,513 | Other acquisition or disposition | $0.00 |
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 10/10.
Innovate Biopharmaceuticals, Inc. is a clinical-stage biopharm Pharmaceutical company. The company is founded by Jay P. Madan and Kendyle Woodard in 2012.